Thrombocytopenia Latest Advances

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Journal: Leukemia & lymphoma

Published: April 15, 2026

Defects in skeletal myotubes caused by STIM1 I115F that lead to tubular aggregate myopathy and Stormorken syndrome and their restoration at the cellular level.

Journal: American journal of physiology. Cell physiology

Published: April 15, 2026

Community-Acquired Methicillin-Resistant Staphylococcus Aureus Pneumonia Complicated by Intracranial Diffuse Thrombotic Microangiopathy.

Journal: Clinical laboratory

Published: April 14, 2026

Refractory systemic lupus erythematosus-associated thrombocytopenia treated with avatrombopag: A case report

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences

Published: April 14, 2026

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program.

Journal: Journal of the advanced practitioner in oncology

Published: April 13, 2026

Retrospective analysis of inotuzumab-associated hepatotoxicity in adult patients with B-cell acute lymphoblastic leukemia: Expanding the Spectrum of calicheamicin syndrome.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: April 10, 2026

Incidence and Clinical Characteristics of Hemorrhagic Manifestations in Children With Influenza: A Multicenter Retrospective Study.

Journal: The Pediatric infectious disease journal

Published: April 10, 2026

Decreased Maximum Amplitude as a Potential Parameter to Predict the Likelihood of Mortality in Complicated Intra-Abdominal Infection Patients with Thrombocytopenia.

Journal: Surgical infections

Published: April 10, 2026

A pharmacological profile of pacritinib for the treatment of myelofibrosis.

Journal: Expert review of clinical pharmacology

Published: April 08, 2026

The role of gene polymorphisms in the susceptibility and therapeutic response of chronic immune thrombocytopenic purpura.

Journal: Expert review of hematology

Published: April 08, 2026

A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia.

Journal: The New England journal of medicine

Published: April 08, 2026

Practical approach to pregnancy-associated thrombotic microangiopathies: navigating diagnostic challenges in resource-limited settings.

Journal: BMJ case reports

Published: April 08, 2026

Thrombocytopenia Latest Advances

Find the Latest Research About Thrombocytopenia

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Defects in skeletal myotubes caused by STIM1 I115F that lead to tubular aggregate myopathy and Stormorken syndrome and their restoration at the cellular level.

Defects in skeletal myotubes caused by STIM1 I115F that lead to tubular aggregate myopathy and Stormorken syndrome and their restoration at the cellular level.

Community-Acquired Methicillin-Resistant Staphylococcus Aureus Pneumonia Complicated by Intracranial Diffuse Thrombotic Microangiopathy.

Community-Acquired Methicillin-Resistant Staphylococcus Aureus Pneumonia Complicated by Intracranial Diffuse Thrombotic Microangiopathy.

Refractory systemic lupus erythematosus-associated thrombocytopenia treated with avatrombopag: A case report

Refractory systemic lupus erythematosus-associated thrombocytopenia treated with avatrombopag: A case report

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program.

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program.

Retrospective analysis of inotuzumab-associated hepatotoxicity in adult patients with B-cell acute lymphoblastic leukemia: Expanding the Spectrum of calicheamicin syndrome.

Retrospective analysis of inotuzumab-associated hepatotoxicity in adult patients with B-cell acute lymphoblastic leukemia: Expanding the Spectrum of calicheamicin syndrome.

Incidence and Clinical Characteristics of Hemorrhagic Manifestations in Children With Influenza: A Multicenter Retrospective Study.

Incidence and Clinical Characteristics of Hemorrhagic Manifestations in Children With Influenza: A Multicenter Retrospective Study.

Decreased Maximum Amplitude as a Potential Parameter to Predict the Likelihood of Mortality in Complicated Intra-Abdominal Infection Patients with Thrombocytopenia.

Decreased Maximum Amplitude as a Potential Parameter to Predict the Likelihood of Mortality in Complicated Intra-Abdominal Infection Patients with Thrombocytopenia.

A pharmacological profile of pacritinib for the treatment of myelofibrosis.

A pharmacological profile of pacritinib for the treatment of myelofibrosis.

The role of gene polymorphisms in the susceptibility and therapeutic response of chronic immune thrombocytopenic purpura.

The role of gene polymorphisms in the susceptibility and therapeutic response of chronic immune thrombocytopenic purpura.

A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia.

A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia.

Practical approach to pregnancy-associated thrombotic microangiopathies: navigating diagnostic challenges in resource-limited settings.

Practical approach to pregnancy-associated thrombotic microangiopathies: navigating diagnostic challenges in resource-limited settings.